PL3380084T3 - Preparaty omeprazolu - Google Patents

Preparaty omeprazolu

Info

Publication number
PL3380084T3
PL3380084T3 PL17767768T PL17767768T PL3380084T3 PL 3380084 T3 PL3380084 T3 PL 3380084T3 PL 17767768 T PL17767768 T PL 17767768T PL 17767768 T PL17767768 T PL 17767768T PL 3380084 T3 PL3380084 T3 PL 3380084T3
Authority
PL
Poland
Prior art keywords
omeprazole formulations
omeprazole
formulations
Prior art date
Application number
PL17767768T
Other languages
English (en)
Inventor
Rok Staric
Bostjan PETEK
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of PL3380084T3 publication Critical patent/PL3380084T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL17767768T 2016-09-07 2017-09-05 Preparaty omeprazolu PL3380084T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16187705.5A EP3292862A1 (en) 2016-09-07 2016-09-07 Omeprazole formulations
PCT/EP2017/072243 WO2018046498A1 (en) 2016-09-07 2017-09-05 Omeprazole formulations
EP17767768.9A EP3380084B1 (en) 2016-09-07 2017-09-05 Omeprazole formulations

Publications (1)

Publication Number Publication Date
PL3380084T3 true PL3380084T3 (pl) 2020-02-28

Family

ID=56888971

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17767768T PL3380084T3 (pl) 2016-09-07 2017-09-05 Preparaty omeprazolu

Country Status (6)

Country Link
US (1) US20200179288A1 (pl)
EP (2) EP3292862A1 (pl)
ES (1) ES2757879T3 (pl)
PL (1) PL3380084T3 (pl)
SI (1) SI3380084T1 (pl)
WO (1) WO2018046498A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118252810B (zh) * 2024-05-30 2024-10-11 寿光富康制药有限公司 一种艾普拉唑肠溶片的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
EP0520119A1 (de) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Neue orale Diclofenaczubereitung
FR2692146B1 (fr) 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
ES2094694B1 (es) 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
GB9710800D0 (en) 1997-05-23 1997-07-23 Cipla Limited Pharmaceutical composition and method of preparing it
EP1108425B1 (en) 1999-12-16 2005-06-08 Laboratorio Medinfar-Produtos Farmaceuticos, S.A. New stable multi-unitary pharmaceutical preparations containing substituted benzimidazoles
CA2494716A1 (en) 2002-08-02 2004-02-19 Ratiopharm Gmbh Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation
EP2331084A4 (en) * 2008-10-06 2014-01-22 Jubilant Life Sciences Ltd PHARMACEUTICAL COMPOSITION WITH AMORPHIC ESOMEPRAZOL AND METHOD OF DOSING THEREOF AND METHOD THEREFOR

Also Published As

Publication number Publication date
EP3292862A1 (en) 2018-03-14
US20200179288A1 (en) 2020-06-11
EP3380084B1 (en) 2019-08-21
ES2757879T3 (es) 2020-04-30
WO2018046498A1 (en) 2018-03-15
EP3380084A1 (en) 2018-10-03
SI3380084T1 (sl) 2020-04-30

Similar Documents

Publication Publication Date Title
IL273541A (en) formulations
IL273282A (en) Niraprib formulations
IL269630A (en) Niraprib formulations
IL269621A (en) Niraparib formulations
IL265609A (en) New formulations
ZA201903101B (en) Pharmaceutical formulations
PT4070787T (pt) Formulações farmacêuticas
IL256491A (en) Pharmaceutical formulations
GB201607918D0 (en) Novel formulations
GB201419091D0 (en) Formulations
IL266867B (en) Nanoparticle formulations
IL262745A (en) Improved preparations containing drugs
GB201419261D0 (en) Formulations
IL254794A0 (en) Pharmaceutical formulations
IL261013A (en) Urethane formulations
SI3380084T1 (sl) Dozirna oblika, ki vsebuje omeprazol
IL254075A (en) Pesticide Resistant Remedies
GB201504482D0 (en) Novel formulations
IL268195A (en) Solid fosmetpantothenate formulations
GB201621277D0 (en) Formulations
GB201618110D0 (en) Formulations
GB201616366D0 (en) Formulations
GB201615754D0 (en) Formulations
GB201714461D0 (en) Formulations
GB201617866D0 (en) Novel formulations